Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Day One Biopharmaceuticals Inc (DAWN)

Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Day One Biopharmaceuticals Inc 2000 Sierra Point Parkway Suite 501 Brisbane CA 94005 USA

www.dayonebio.com Employees: 155 P: 650-484-0899

Description:

Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 1,373,523
Enterprise Value, $K 1,142,743
Shares Outstanding, K 100,846
Annual Sales, $ 0 K
Annual Net Income, $ -188,920 K
Last Quarter Sales, $ 93,760 K
Last Quarter Net Income, $ 37,040 K
EBIT, $ -211,460 K
EBITDA, $ -211,080 K
60-Month Beta -1.51
% of Insider Shareholders 8.40%
% of Institutional Shareholders 87.95%
Float, K 92,375
% Float 91.60%
Short Volume Ratio 0.65

Growth:

1-Year Return 13.09%
3-Year Return -25.57%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.38 on 10/30/24
Next Earnings Date N/A
Earnings Per Share ttm -1.03
EPS Growth vs. Prev Qtr 860.00%
EPS Growth vs. Prev Year 170.37%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

DAWN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -22.40%
Return-on-Assets % -19.79%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 11.91
Price/Cash Flow N/A
Price/Book 2.45
Book Value/Share 5.51
Interest Coverage -1.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar